A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Repeated Intra-Articular Injection of SI-613 in Patients With Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2018
At a glance
- Drugs Diclofenac-Eatlhyaluronate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Seikagaku Corporation
- 26 Nov 2018 Status changed from active, no longer recruiting to completed.
- 31 May 2018 Status changed from recruiting to active, no longer recruiting.
- 24 Oct 2017 Status changed from not yet recruiting to recruiting.